Willem F Lems (W F Lems, W Lems, Willem Lems, M van der Esch)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 35

Top Topics

Rheumatoid Arthritis

Disease Activity

Top Venues

Annals of the rheumatic diseases

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA

Archives of osteoporosis

This page only lists publications with an associated author ORCID identifier.

Publications

Joy Ardjuna van der Pol, Cornelia F Allaart, Willem F Lems, Sjoerd M van der Kooij, Thomas Wj Huizinga, Sytske Anne Bergstra
Prednisone use, disease activity and the occurrence of hyperglycaemia and diabetes in patients with early rheumatoid arthritis: a 10-year subanalysis of the BeSt study. RMD open 10 (2) (2024)
Willem F Lems, Joop P van den Bergh, Piet Geusens
Follow-up in Fracture Liaisons Services: the involvement of general practitioners and fracture nurses is urgently needed. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA (2024)
Anneke F Marsman, Renate T de Jongh, Bernd P Teunissen, Willem F Lems
Bone loss and new vertebral fractures during treatment with romosozumab: a case-report. Archives of osteoporosis 19 (1) (2024)
Joy Ardjuna van der Pol, Cornelia F Allaart, Willem F Lems, Sjoerd M van der Kooij, Thomas Wj Huizinga, Sytske Anne Bergstra
Prednisone use, disease activity and the occurrence of hyperglycaemia and diabetes in patients with early rheumatoid arthritis: a 10-year subanalysis of the BeSt study. RMD open 10 (2) (2024)
Willem F Lems, Joop P van den Bergh, Piet Geusens
Follow-up in Fracture Liaisons Services: the involvement of general practitioners and fracture nurses is urgently needed. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 35 (6) (2024)
Anneke F Marsman, Renate T de Jongh, Bernd P Teunissen, Willem F Lems
Bone loss and new vertebral fractures during treatment with romosozumab: a case-report. Archives of osteoporosis 19 (1) (2024)
Joy Ardjuna van der Pol, Cornelia F Allaart, Willem F Lems, Sjoerd M van der Kooij, Thomas Wj Huizinga, Sytske Anne Bergstra
Prednisone use, disease activity and the occurrence of hyperglycaemia and diabetes in patients with early rheumatoid arthritis: a 10-year subanalysis of the BeSt study. RMD open 10 (2) (2024)
Anneke F Marsman, Renate T de Jongh, Bernd P Teunissen, Willem F Lems
Bone loss and new vertebral fractures during treatment with romosozumab: a case-report. Archives of osteoporosis 19 (1) (2024)
Joy Ardjuna van der Pol, Cornelia F Allaart, Willem F Lems, Sjoerd M van der Kooij, Thomas Wj Huizinga, Sytske Anne Bergstra
Prednisone use, disease activity and the occurrence of hyperglycaemia and diabetes in patients with early rheumatoid arthritis: a 10-year subanalysis of the BeSt study. RMD open 10 (2) (2024)
Anneke F Marsman, Renate T de Jongh, Bernd P Teunissen, Willem F Lems
Bone loss and new vertebral fractures during treatment with romosozumab: a case-report. Archives of osteoporosis 19 (1) (2024)
Sascha Louise Heckert, Johanna Maria Maassen, S le Cessie, Y P M Goekoop-Ruiterman, Melek Güler-Yüksel, Willem F Lems, Thomas Wj Huizinga, Sytske Anne Bergstra, Cornelia F Allaart
Long-term mortality in treated-to-target RA and UA: results of the BeSt and IMPROVED cohort. Annals of the rheumatic diseases (2023)
Sascha Louise Heckert, Sytske Anne Bergstra, Yvonne P M Goekoop-Ruiterman, Melek Güler-Yüksel, Willem F Lems, Xanthe Marijn Edmée Matthijssen, Maikel van Oosterhout, Thomas Wj Huizinga, Cornelia F Allaart
Frequency of joint inflammation is associated with local joint damage progression in rheumatoid arthritis despite long-term targeted treatment. RMD open 9 (1) (2023)
Willem F Lems, Hennie G Raterman, Piet P M M Geusens
High Frequency of Foot Insufficiency Fractures in Patients With Rheumatic Diseases Referred for Magnetic Resonance Imaging: What Is the Clinical Relevance? The Journal of rheumatology (2023)
Lotte van Ouwerkerk, Patrick Verschueren, Maarten Boers, Paul Emery, Pascal Hendrik Pieter de Jong, Robert B M Landewe, Willem F Lems, Josef S Smolen, Thomas Wj Huizinga, Cornelia F Allaart, Sytske Anne Bergstra
Initial glucocorticoid bridging in rheumatoid arthritis: does it affect glucocorticoid use over time? Annals of the rheumatic diseases (2023)
M Sobejana, Willem F Lems, J van den Hoek, George D Kitas, Marike van der Leeden, Michael T Nurmohamed, Georgios S Metsios
Do Disease-Modifying Anti-rheumatic Drugs and Exercise Therapy Have a Combined Effect on Disease Activity in Patients with RA? A Scoping Review. Current rheumatology reports (2023)
Sascha Louise Heckert, Sytske Anne Bergstra, Yvonne P M Goekoop-Ruiterman, Melek Güler-Yüksel, Willem F Lems, Xanthe Marijn Edmée Matthijssen, Maikel van Oosterhout, Thomas Wj Huizinga, Cornelia F Allaart
Frequency of joint inflammation is associated with local joint damage progression in rheumatoid arthritis despite long-term targeted treatment. RMD open 9 (1) (2023)
Willem F Lems, Jan Tuckermann, Barbara Hauser
Osteo-Immunology and Hip Fractures. Calcified tissue international (2023)
Sascha Louise Heckert, Sytske Anne Bergstra, Yvonne P M Goekoop-Ruiterman, Melek Güler-Yüksel, Willem F Lems, Xanthe Marijn Edmée Matthijssen, Maikel van Oosterhout, Thomas Wj Huizinga, Cornelia F Allaart
Frequency of joint inflammation is associated with local joint damage progression in rheumatoid arthritis despite long-term targeted treatment. RMD open 9 (1) (2023)
Abdullah Ali Hadi Almayali, Maarten Boers, Linda Hartman, Daniela Opris, Reinhard Bos, Marc-Redwart Kok, José António Pereira Da Silva, Ed Griep, Ruth Klaasen, Cornelia F Allaart, Paul Baudoin, Hennie G Raterman, Zoltán Szekanecz, Frank Buttgereit, Pavol Masaryk, Willem F Lems, Yvo Smulders, Maurizio Cutolo, Marieke M Ter Wee
Three-month tapering and discontinuation of long- term, low-dose glucocorticoids in senior patients with rheumatoid arthritis is feasible and safe: placebo-controlled double blind tapering after the GLORIA trial. Annals of the rheumatic diseases (2023)
Laura Boekel, Femke Hooijberg, Erik H Vogelzang, Yaëlle R Besten, Maureen Leeuw, Sadaf Atiqi, Ronald F Van Vollenhoven, Carla A Wijbrandts, Martijn Gerritsen, Charlotte Lm Krieckaert, Bas Dijkshoorn, Siham Bakhlakh, Juliette J Crooijmans, Alexandre Voskuyl, Irene E van der Horst-Bruinsma, Willem F Lems, Taco W Kuijpers, S Marieke van Ham, Luuk Wieske, Filip Eftimov, Laura Y Kummer, Pj Koos van Dam, Eileen W Stalman, Maurice Steenhuis, Sofie Keijzer, Olvi Cristianawati, Jim Keijser, Floris C Loeff, Sander W Tas, Michael T Nurmohamed, Maarten Boers, Theo Rispens, Gertjan Wolbink
Antibody development and disease severity of COVID-19 in non-immunised patients with rheumatic immune-mediated inflammatory diseases: data from a prospective cohort study. RMD open 8 (1) (2022)
Nicki Verweij, Gerben Zwezerijnen, Marieke Ter Wee, Jerney de Jongh, Maqsood Yaqub, Dirkjan van Schaardenburg, Adriaan Lammertsma, Alexandre Voskuyl, Willem F Lems, Maarten Boers, Conny van der Laken
Early prediction of treatment response in rheumatoid arthritis by quantitative macrophage PET. RMD open 8 (1) (2022)
M Sobejana, J van den Hoek, Georgios S Metsios, George D Kitas, Marike van der Leeden, S Verberne, Harald T Jørstad, Mirjam Pijnappels, Willem F Lems, Michael T Nurmohamed, M van der Esch
Exercise intervention on cardiorespiratory fitness in rheumatoid arthritis patients with high cardiovascular disease risk: a single-arm pilot study. Clinical rheumatology 41 (12) (2022)
Lotte van Ouwerkerk, Maarten Boers, Paul Emery, Pascal Hendrik Pieter de Jong, Robert B M Landewe, Willem F Lems, Josef S Smolen, Patrick Verschueren, Thomas Wj Huizinga, Cornelia F Allaart, Sytske Anne Bergstra
Individual patient data meta-analysis on continued use of glucocorticoids after their initiation as bridging therapy in patients with rheumatoid arthritis. Annals of the rheumatic diseases (2022)
Maarten Boers, Linda Hartman, Daniela Opris-Belinski, Reinhard Bos, Marc-Redwart Kok, José António Pereira Da Silva, Eduard N Griep, Ruth Klaasen, Cornelia F Allaart, Paul Baudoin, Hennie G Raterman, Zoltán Szekanecz, Frank Buttgereit, Pavol Masaryk, L Thomas Klausch, Sabrina Paolino, Annemarie M Schilder, Willem F Lems, Maurizio Cutolo, null null
Low dose, add-on prednisolone in patients with rheumatoid arthritis aged 65+: the pragmatic randomised, double-blind placebo-controlled GLORIA trial. Annals of the rheumatic diseases 81 (7) (2022)
Willem F Lems, Corinne Miceli-Richard, Judith Haschka, Andrea Giusti, Gitte Lund Chistensen, Roland Kocijan, Nicolas Rosine, Niklas Rye Jørgensen, Gerolamo Bianchi, Christian Roux
Bone Involvement in Patients with Spondyloarthropathies. Calcified tissue international 110 (4) (2022)
Abdulbaqi Al-Toma, Amin Herman, Willem F Lems, Chris J J Mulder
The Dietary and Non-Dietary Management of Osteoporosis in Adult-Onset Celiac Disease: Current Status and Practical Guidance. Nutrients 14 (21) (2022)
Piet Geusens, Natasha Appelman-Dijkstra, Willem F Lems, Joop van den Bergh
Romosozumab for the treatment of postmenopausal women at high risk of fracture. Expert opinion on biological therapy (2022)
S C Heslinga, Charlotte E Teunissen, Rabia Agca, Diane van der Woude, Thomas Wj Huizinga, Jacob M van Laar, Alfons A den Broeder, Willem F Lems, Michael T Nurmohamed
NT-proBNP and sRAGE levels in early rheumatoid arthritis. Scandinavian journal of rheumatology (2022)
Renske C F Hebing, Marry Lin, Maja Bulatovic Calasan, Ittai B Muller, Sohaila Mahmoud, Sandra Heil, Eduard A Struys, Bart Jf van den Bemt, Jos Wr Twisk, Willem F Lems, Michael T Nurmohamed, Gerrit Jansen, Robert de Jonge
Pharmacokinetics of oral and subcutaneous methotrexate in red and white blood cells in patients with early rheumatoid arthritis: the methotrexate monitoring trial. Annals of the rheumatic diseases (2022)
Josien C van den Noort, Marike van der Leeden, Gerard Stapper, Wolfgang Wirth, Mario Maas, Leo D Roorda, Willem F Lems, Joost Dekker, Martin van der Esch
Muscle weakness is associated with non-contractile muscle tissue of the vastus medialis muscle in knee osteoarthritis. BMC musculoskeletal disorders 23 (1) (2022)
Willem F Lems, Maarten Boers, Ronald F Van Vollenhoven, Mike Nurmohamed
Antirheumatic drugs for cardiovascular disease prevention: the case for colchicine. RMD open 7 (1) (2021)
Willem F Lems, J Paccou, J Zhang, N R Fuggle, M Chandran, N C Harvey, C Cooper, K Javaid, S Ferrari, K E Akesson, null null
Vertebral fracture: epidemiology, impact and use of DXA vertebral fracture assessment in fracture liaison services. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 32 (3) (2021)
M Sobejana, J van den Hoek, Georgios S Metsios, George D Kitas, Harald T Jørstad, Marike van der Leeden, Mirjam Pijnappels, Willem F Lems, Michael T Nurmohamed, Martin van der Esch
Cardiorespiratory fitness and physical activity in people who have rheumatoid arthritis at an increased risk of cardiovascular disease: a cross-sectional study. Rheumatology international 41 (12) (2021)
M J J Lucassen, Marieke M Ter Wee, D den Uyl, N P C Konijn, Michael T Nurmohamed, Alexandre E Voskuyl, Dirkjan van Schaardenburg, P J S M Kerstens, Irene E M Bultink, Maarten Boers, Willem F Lems
Long-term effects on bone mineral density after four years of treatment with two intensive combination strategies, including initially high-dose prednisolone, in early rheumatoid arthritis patients: the COBRA-light trial. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 32 (7) (2021)
A H de Zwart, Marike van der Leeden, Leo D Roorda, M Visser, Martin van der Esch, Willem F Lems, Joost Dekker
Dietary protein intake and upper leg muscle strength in subjects with knee osteoarthritis: data from the osteoarthritis initiative. Rheumatology international 39 (2) (2019)